HALİS, F. Et Al. 2021. Effects of 5 alpha-reductase inhibitor therapy with dutasteride on bone metabolism in patients with benign prostatic hyperplasia. KUWAIT MEDICAL JOURNAL , vol.53, no.2 , 162-166.

HALİS, F., OĞUZ, U., ÇİMEN, H. İ., Atik, Y. T., BAYDİLLİ, N., & GÖKÇE, A., (2021). Effects of 5 alpha-reductase inhibitor therapy with dutasteride on bone metabolism in patients with benign prostatic hyperplasia. KUWAIT MEDICAL JOURNAL , vol.53, no.2, 162-166.

HALİS, FİKRET Et Al. "Effects of 5 alpha-reductase inhibitor therapy with dutasteride on bone metabolism in patients with benign prostatic hyperplasia," KUWAIT MEDICAL JOURNAL , vol.53, no.2, 162-166, 2021

HALİS, FİKRET Et Al. "Effects of 5 alpha-reductase inhibitor therapy with dutasteride on bone metabolism in patients with benign prostatic hyperplasia." KUWAIT MEDICAL JOURNAL , vol.53, no.2, pp.162-166, 2021

HALİS, F. Et Al. (2021) . "Effects of 5 alpha-reductase inhibitor therapy with dutasteride on bone metabolism in patients with benign prostatic hyperplasia." KUWAIT MEDICAL JOURNAL , vol.53, no.2, pp.162-166.

@article{article, author={FİKRET HALİS Et Al. }, title={Effects of 5 alpha-reductase inhibitor therapy with dutasteride on bone metabolism in patients with benign prostatic hyperplasia}, journal={KUWAIT MEDICAL JOURNAL}, year=2021, pages={162-166} }